Literature DB >> 15714084

Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study.

Deborah Marsden1.   

Abstract

PURPOSE: To review the narratives that detailed the most important features of Infantile Onset Pompe disease (IOPD) from the physician's perspective, submitted as part of a large multicenter, multinational epidemiologic natural history study.
METHODS: Inclusion in the epidemiologic study required documentation of onset of symptoms in the first 12 months of age and GAA enzyme deficiency or GAA mutation(s). In all, 300 cases were screened; 168 cases from 33 study sites in 9 countries met all eligibility criteria. In addition, 125 narratives that summarized the most important clinical features of IOPD, reflecting the opinion of the participating physicians who had provided access to the records for the independent review, were analyzed and are reported separately. A total of 98 variables were analyzed.
RESULTS: Hypotonia was the most common presenting symptom, occurring in 75% of patients; muscle weakness was a presenting symptom in 59% of patients. The most frequent sign noted on physical examination was hypotonia (82%); respiratory distress, cardiomegaly, weakness, and cardiac failure were also frequent. Progression of disease was characterized by increased respiratory distress (72%), hypotonia (66%), and cardiac failure (58%). The most frequent supportive treatments were cardiac medications (52%) and oxygen supplementation (35%). Little psychosocial information was included.
CONCLUSION: Physician narratives provide a unique perspective on the natural history of IOPD and are useful adjuncts to other data collection. Overall, there was concordance with the data obtained by the independent abstractors.

Entities:  

Mesh:

Year:  2005        PMID: 15714084     DOI: 10.1097/01.gim.0000154301.76619.5c

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  12 in total

1.  Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines.

Authors:  Mai K ElMallah; Silvia Pagliardini; Sara M Turner; Anthony J Cerreta; Darin J Falk; Barry J Byrne; John J Greer; David D Fuller
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

2.  Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.

Authors:  Daniel A Morris; Daniela Blaschke; Alice Krebs; Sima Canaan-Kühl; Ursula Plöckinger; Gesine Knobloch; Thula C Walter; York Kühnle; Leif-Hendrik Boldt; Elisabeth Kraigher-Krainer; Burkert Pieske; Wilhelm Haverkamp
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-06       Impact factor: 2.357

3.  Airway smooth muscle dysfunction in Pompe (Gaa-/- ) mice.

Authors:  Allison M Keeler; Donghai Liu; Marina Zieger; Lang Xiong; Jeffrey Salemi; Karl Bellvé; Barry J Byrne; David D Fuller; Ronghua ZhuGe; Mai K ElMallah
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-23       Impact factor: 5.464

Review 4.  The respiratory neuromuscular system in Pompe disease.

Authors:  David D Fuller; Mai K ElMallah; Barbara K Smith; Manuela Corti; Lee Ann Lawson; Darin J Falk; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2013-06-21       Impact factor: 1.931

5.  Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy.

Authors:  Paul T McIntosh; Lisa D Hobson-Webb; Zoheb B Kazi; Sean N Prater; Suhrad G Banugaria; Stephanie Austin; Raymond Wang; David S Enterline; Donald P Frush; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2017-10-13       Impact factor: 4.797

6.  "Double-trouble" for respiratory control in pompe disease.

Authors:  Ken D O'Halloran
Journal:  Front Physiol       Date:  2011-09-01       Impact factor: 4.566

7.  Pompe disease diagnosis and management guideline.

Authors:  Priya S Kishnani; Robert D Steiner; Deeksha Bali; Kenneth Berger; Barry J Byrne; Laura E Case; Laura Case; John F Crowley; Steven Downs; R Rodney Howell; Richard M Kravitz; Joanne Mackey; Deborah Marsden; Anna Maria Martins; David S Millington; Marc Nicolino; Gwen O'Grady; Marc C Patterson; David M Rapoport; Alfred Slonim; Carolyn T Spencer; Cynthia J Tifft; Michael S Watson
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

8.  Hypoglossal neuropathology and respiratory activity in pompe mice.

Authors:  Kun-Ze Lee; Kai Qiu; Milapjit S Sandhu; Mai K Elmallah; Darin J Falk; Michael A Lane; Paul J Reier; Barry J Byrne; David D Fuller
Journal:  Front Physiol       Date:  2011-06-30       Impact factor: 4.566

9.  Familial Pompe Disease.

Authors:  Mehmet Tecellioglu; Ozden Kamisli
Journal:  Med Arch       Date:  2015-10-04

10.  A review of treatment of Pompe disease in infants.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.